Altamira Therapeutics Ltd.: Altamira Therapeutic's RNA Delivery Platform Shown to be an Effective Treatment for Abdominal Aortic Aneurysm as Published in Peer-Reviewed Journal

Study results appeared in "Biomaterials Advances", a highly respected peer-reviewed journal, showcasing growing medical recognition of Company's patented RNA delivery platform for extrahepatic targets.Company's

Related Keywords

Bermuda ,United States ,Switzerland ,Samuel Wickline ,Securities Exchange Commission ,National Institutes Of Health ,Veterans Administration ,Washington University ,Altamira Therapeutics Ltd ,Securities Exchange ,Elsevier ,Altamira Therapeutics ,Biomaterials Advances ,Chief Scientific Officer ,National Institutes ,Aortic Aneurysm ,Severe Condition Lacking Non Surgical Treatment ,Materials Today Bio ,Materials Today ,Securities Act ,Securities Exchange Act ,Altamira Therapeutic ,Altamira Therapeutic Annual Report ,Altamira ,Herapeutics ,Herapeutic ,Delivery ,Platform ,Hown ,Ffective ,Treatment ,Prabdominal ,Aortic ,Aneurysm ,Published ,Beer ,Eviewed ,Journal ,